The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2’deoxycytidine (decitabine) are differentially regulated by cell cycle progression-Reference-Cited by-同舟云学术

The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2’deoxycytidine (decitabine) are differentially regulated by cell cycle progression

Published:2011-08 Issue:8 Volume:6 Page:1021-1028
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Al-Salihi Mazin,Yu Margaret,Burnett David M.,Alexander Amanda,Samlowski Wolfram E.,Fitzpatrick Frank A.

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/epi.6.8.16064

Reference39 articles.

1. Epigenetics in Cancer

2. Targeting DNA Methylation

3. Low-Dose 5-Aza-2′-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients

4. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies

5. Evaluation of a 7-Day Continuous Intravenous Infusion of Decitabine: Inhibition of Promoter-Specific and Global Genomic DNA Methylation

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prothymosin α accelerates dengue virus-induced thrombocytopenia;iScience;2024-01

2. SAM targeting methylation by the methyl donor, a novel therapeutic strategy for antagonize PFOS transgenerational fertilitty toxicity;Ecotoxicology and Environmental Safety;2019-11

3. Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients;Future Oncology;2019-06

4. Epigenetic Targeting of Adipocytes Inhibits High-Grade Serous Ovarian Cancer Cell Migration and Invasion;Molecular Cancer Research;2018-05-14

5. NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2′,2′-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer;Pharmaceuticals;2018-04-23